Literature DB >> 16908373

Wanted: A study with omalizumab to determine the role of IgE-mediated pathways in atopic dermatitis.

Lisa A Beck, Sarbjit Saini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16908373     DOI： 10.1016/j.jaad.2006.01.037

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

Review 1.  IgE, mast cells, and eosinophils in atopic dermatitis.

Authors:  Fu-Tong Liu; Heidi Goodarzi; Huan-Yuan Chen
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 8.667

2.  [Omalizumab as a therapeutic option in atopic eczema. Current evidence and potential benefit].

Authors:  J Schmitt; K Schäkel
Journal:  Hautarzt       Date:  2007-02       Impact factor: 0.751

Review 3.  Systemic therapy of atopic dermatitis in children.

Authors:  Giampaolo Ricci; Arianna Dondi; Annalisa Patrizi; Massimo Masi
Journal:  Drugs       Date:  2009       Impact factor: 9.546

4.  Current and future applications of the anti-IgE antibody omalizumab.

Authors:  Cristoforo Incorvaia; Marina Mauro; Gian Galeazzo Riario-Sforza; Franco Frati; Francesco Tarantini; Maurizio Caserini
Journal:  Biologics       Date:  2008-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.